Clark Mitchall G.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$7.86M

Insider Activity of Clark Mitchall G.

The largest sale of all time was on 2018-03-27 and amounted to 100203 shares of Atara Biotherapeutics, Inc. for $3.8M.

Biography of Clark Mitchall G.

No biography is available at this moment.

2018-05-18SaleAtara Biotherapeutics, Inc.
ATRA
EVP & Chief R & QA Officer
25,860
0.0582%
$50.03$1.29M-23.74%
2018-05-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP & Chief R & QA Officer
4,647
0.0102%
$46.06$214,026-19.24%
2018-03-29SaleAtara Biotherapeutics, Inc.
ATRA
EVP & Chief R & QA Officer
22,400
0.0581%
$40.07$897,568-0.13%
2018-03-27SaleAtara Biotherapeutics, Inc.
ATRA
EVP & Chief R & QA Officer
100,203
0.2489%
$37.87$3.8M+1.17%
2017-11-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP & Chief R & QA Officer
3,290
0.0108%
$14.20$46,718+167.93%
2017-08-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP & Chief R & QA Officer
3,021
0.0099%
$14.33$43,291+156.1%
2017-05-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP & Chief R & QA Officer
7,746
0.0265%
$15.25$118,127+1.15%
2017-02-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP & Chief R & QA Officer
6,118
0.0215%
$15.96$97,643-2.24%
2016-11-16SaleAtara Biotherapeutics, Inc.
ATRA
Chief R & QA Officer
5,990
0.022%
$19.53$116,985-17.7%
2016-05-16SaleAtara Biotherapeutics, Inc.
ATRA
Chief R & QA Officer
8,306
0.0269%
$15.15$125,836+13.31%
2016-02-16SaleAtara Biotherapeutics, Inc.
ATRA
Chief R & QA Officer
8,306
0.0287%
$15.35$127,497+18.74%
2015-11-16SaleAtara Biotherapeutics, Inc.
ATRA
Chief R & QA Officer
8,306
0.0331%
$31.67$263,051-35.8%
2015-08-17SaleAtara Biotherapeutics, Inc.
ATRA
Chief R & QA Officer
15,658
0.0522%
$46.19$723,243-55.93%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.